Jia Zhanjun, Zhuang Yibo, Hu Caiyu, Zhang Xintong, Ding Guixia, Zhang Yue, Rohatgi Rajeev, Hua Hu, Huang Songming, He John Ci-Jiang, Zhang Aihua
Department of Nephrology, Nanjing Children's Hospital, Affiliated with Nanjing Medical University, Nanjing, China.
Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.
Oncotarget. 2016 Jul 26;7(30):47134-47144. doi: 10.18632/oncotarget.9972.
Imbalance of salt and water is a frequent and challenging complication of kidney disease, whose pathogenic mechanisms remain elusive. Employing an albumin overload mouse model, we discovered that albuminuria enhanced the expression of NHE3 and NCC but not other transporters in murine kidney in line with the stimulation of angiotensinogen (AGT)/angiotensin converting enzyme (ACE)/angiotensin (Ang) II cascade. In primary cultures of renal tubular cells, albumin directly stimulated AGT/ACE/Ang II and upregulated NHE3 and NCC expression. Blocking Ang II production with an ACE inhibitor normalized the upregulation of NHE3 and NCC in cells. Interestingly, albumin overload significantly reduced mitochondrial superoxide dismutase (SOD2), and administration of a SOD2 mimic (MnTBAP) normalized the expression of NHE3, NCC, and the components of AGT/ACE pathway affected by albuminuria, indicating a key role of mitochondria-derived oxidative stress in modulating renin-angiotensin system (RAS) and renal sodium transporters. In addition, the functional data showing the reduced urinary excretion of Na and Cl and enhanced response to specific NCC inhibitor further supported the regulatory results of sodium transporters following albumin overload. More importantly, the upregulation of NHE3 and NCC and activation of ACE/Ang II signaling pathway were also observed in albuminuric patient kidneys, suggesting that our animal model accurately replicates the human condition. Taken together, these novel findings demonstrated that albuminuria is of importance in resetting renal salt handling via mitochondrial oxidative stress-initiated stimulation of ACE/Ang II cascade. This may also offer novel, effective therapeutic targets for dealing with salt and water imbalance in proteinuric renal diseases.
水盐失衡是肾脏疾病常见且具有挑战性的并发症,其致病机制仍不清楚。利用白蛋白过载小鼠模型,我们发现蛋白尿增强了小鼠肾脏中NHE3和NCC的表达,但未增强其他转运蛋白的表达,这与血管紧张素原(AGT)/血管紧张素转换酶(ACE)/血管紧张素(Ang)II级联反应的刺激一致。在肾小管细胞原代培养中,白蛋白直接刺激AGT/ACE/Ang II并上调NHE3和NCC的表达。用ACE抑制剂阻断Ang II的产生可使细胞中NHE3和NCC的上调恢复正常。有趣的是,白蛋白过载显著降低了线粒体超氧化物歧化酶(SOD2),给予SOD2模拟物(MnTBAP)可使受蛋白尿影响的NHE3、NCC和AGT/ACE途径成分的表达恢复正常,表明线粒体衍生的氧化应激在调节肾素-血管紧张素系统(RAS)和肾钠转运蛋白中起关键作用。此外,功能数据显示钠和氯的尿排泄减少以及对特定NCC抑制剂的反应增强,进一步支持了白蛋白过载后钠转运蛋白的调节结果。更重要的是,在蛋白尿患者的肾脏中也观察到了NHE3和NCC的上调以及ACE/Ang II信号通路的激活,这表明我们的动物模型准确地复制了人类情况。综上所述,这些新发现表明,蛋白尿在通过线粒体氧化应激引发的ACE/Ang II级联反应刺激来重置肾脏盐处理方面具有重要意义。这也可能为处理蛋白尿性肾脏疾病中的水盐失衡提供新的有效治疗靶点。